These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6874387

  • 1. Factitious hypertension with mineralocorticoid excess in an infant.
    De Stefano P, Bongo IG, Borgna-Pignatti C, Severi F.
    Helv Paediatr Acta; 1983 May; 38(2):185-9. PubMed ID: 6874387
    [Abstract] [Full Text] [Related]

  • 2. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
    Foresti V, Parisio E, Ricci G.
    Minerva Med; 1987 Sep 15; 78(17):1305-11. PubMed ID: 2444906
    [Abstract] [Full Text] [Related]

  • 3. [Hypokalemic myopathy in arterial hypertension].
    Santeusanio F, Nunzi E, Natali P, Nicoletti I, Angeletti G, Filipponi P, Rambotti P.
    Minerva Med; 1982 Sep 15; 73(35):2279-86. PubMed ID: 7110606
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin.
    Montoliu J, Botey A, Trilla A, Revert L.
    Clin Nephrol; 1984 Nov 15; 22(5):262-6. PubMed ID: 6394185
    [Abstract] [Full Text] [Related]

  • 6. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
    Mantero F, Armanini D, Opocher G, Fallo F, Sampieri L, Cuspidi B, Ambrosi C, Faglia G.
    Am J Med; 1981 Sep 15; 71(3):352-7. PubMed ID: 6169277
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases].
    Cantello R, Bergamini L, Delsedime M, Durelli L, Troni W, Gilli M, Cocito D.
    Minerva Med; 1983 Jun 16; 74(25):1463-7. PubMed ID: 6856155
    [Abstract] [Full Text] [Related]

  • 10. Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray.
    Vita G, Bartolone S, Santoro M, Toscano A, Carrozza G, Girlanda P, Frisina N.
    Clin Neuropathol; 1987 Jun 16; 6(2):80-5. PubMed ID: 3594977
    [Abstract] [Full Text] [Related]

  • 11. [Arterial hypertension induced by an excess of mineralocorticoids caused by abuse of nasal spray. Report of a case].
    De Venuto G, Mattarei M, Dal Piaz A, De Santa A, Torboli PL, Miori R.
    Minerva Med; 1984 Jun 30; 75(27):1673-77. PubMed ID: 6205328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.
    Armbruster H, Vetter W, Reck G, Beckerhoff R, Siegenthaler W.
    Int J Clin Pharmacol Biopharm; 1975 Jul 30; 12(1-2):170-3. PubMed ID: 51837
    [Abstract] [Full Text] [Related]

  • 14. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
    Chamontin B, Blanchouin-Emeric N, Amar J, Khatibi F, Vernier I, Bennet A, Aupetit-Faisant B, Salvador M.
    Arch Mal Coeur Vaiss; 1996 Aug 30; 89(8):1055-8. PubMed ID: 8949378
    [Abstract] [Full Text] [Related]

  • 15. [Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments].
    Arnal JM, Moneo MI, Loris C.
    An Esp Pediatr; 1987 Jan 30; 26(1):65-6. PubMed ID: 3826948
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.